| pubmed-article:15692848 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15692848 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:15692848 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
| pubmed-article:15692848 | lifeskim:mentions | umls-concept:C1538265 | lld:lifeskim |
| pubmed-article:15692848 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:15692848 | lifeskim:mentions | umls-concept:C0209368 | lld:lifeskim |
| pubmed-article:15692848 | lifeskim:mentions | umls-concept:C0600554 | lld:lifeskim |
| pubmed-article:15692848 | lifeskim:mentions | umls-concept:C0591833 | lld:lifeskim |
| pubmed-article:15692848 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:15692848 | pubmed:dateCreated | 2005-2-4 | lld:pubmed |
| pubmed-article:15692848 | pubmed:abstractText | Graft-versus-leukemia (GVL) effect is an essential component in the course of allogeneic stem cell transplantation (SCT). However, both prevention and treatment of established graft-versus-host disease (GVHD), including with drugs such as cyclosporine, can suppress GVL effects. Mycophenolate mofetil (MMF) is becoming a standard of care in SCT recipients for better prevention of GVHD as well as for promoting stem cell engraftment. | lld:pubmed |
| pubmed-article:15692848 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15692848 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15692848 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15692848 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15692848 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15692848 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15692848 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15692848 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15692848 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15692848 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:15692848 | pubmed:issn | 0340-7004 | lld:pubmed |
| pubmed-article:15692848 | pubmed:author | pubmed-author:KasirJudithJ | lld:pubmed |
| pubmed-article:15692848 | pubmed:author | pubmed-author:SlavinShimonS | lld:pubmed |
| pubmed-article:15692848 | pubmed:author | pubmed-author:WeissLolaL | lld:pubmed |
| pubmed-article:15692848 | pubmed:author | pubmed-author:ResnickIgor... | lld:pubmed |
| pubmed-article:15692848 | pubmed:author | pubmed-author:OrReuvenR | lld:pubmed |
| pubmed-article:15692848 | pubmed:author | pubmed-author:ShapiraMichae... | lld:pubmed |
| pubmed-article:15692848 | pubmed:author | pubmed-author:ZeiraMichaelM | lld:pubmed |
| pubmed-article:15692848 | pubmed:author | pubmed-author:HirshfeldEste... | lld:pubmed |
| pubmed-article:15692848 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15692848 | pubmed:volume | 54 | lld:pubmed |
| pubmed-article:15692848 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15692848 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15692848 | pubmed:pagination | 383-8 | lld:pubmed |
| pubmed-article:15692848 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:meshHeading | pubmed-meshheading:15692848... | lld:pubmed |
| pubmed-article:15692848 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15692848 | pubmed:articleTitle | Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine model. | lld:pubmed |
| pubmed-article:15692848 | pubmed:affiliation | Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah-Hebrew University Medical Center, PO Box 12000, 91120, Jerusalem, Israel. shapiram@hadassah.org.il | lld:pubmed |
| pubmed-article:15692848 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15692848 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15692848 | lld:pubmed |
